The impact of migraine: Epidemiology, risk factors, and co-morbidities.
about
The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraineMigraine in the borderland of epilepsy: "migralepsy" an overlapping syndrome of children and adults?The effectiveness of spinal manipulation for the treatment of headache disorders: a systematic review of randomized clinical trials.New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary CareSerum calcium and risk of migraine: a Mendelian randomization studyMigraine among medical students in Kuwait UniversityA twin study of depression and migraine: evidence for a shared genetic vulnerability.Psychiatric comorbidity and suicide risk in patients with chronic migraineThe Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.Efficacy of zonisamide in migraineurs with nonresponse to topiramate.Clinical guidelines in pediatric headache: evaluation of quality using the AGREE II instrumentEletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.Dietary aspects of migraine trigger factors.Comparison of the effects of dietary factors in the management and prophylaxis of migraine.Migraine-associated risks and comorbidity.Lay versus expert interviewers for the diagnosis of migraine in a large sample of elderly peopleEfficacy and tolerability of almotriptan in postmarketing surveillance studies.Migraine prevalence, alexithymia, and post-traumatic stress disorder among medical students in Turkey.Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.Menstrual migraine: pathophysiology, diagnosis, and impact.Psychological risk factors in headacheNeurovascular pains: implications of migraine for the oral and maxillofacial surgeon.Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet UniversityMigraine and chronic daily headache management: implications for primary care practitioners.Investigation between the S377G3 GATA-4 polymorphism and migraine.Migraine as a sex-conditioned inherited disorder: evidences from China and the world.Panic disorder and migraine: comorbidity, mechanisms, and clinical implications.Sex disparities in neuro-ophthalmologic disorders.The Frequent Unusual Headache Syndromes: A Proposed Classification Based on Lifetime Prevalence.Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.Blood pressure changes in migraine patients before, during and after migraine attacks.Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance.Evaluation of migraine in patients with ischaemic stroke.Subjective cognitive decline in patients with migraine and its relationship with depression, anxiety, and sleep quality.Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study.Familial risks for migraine and other headaches among siblings based on hospitalizations in Sweden.Topiramate-induced intractable cough during migraine prophylaxis.Health-related quality of life measures and psychiatric comorbidity in patients with migraine.Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors.Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan.
P2860
Q27008834-8F656B23-22AF-4F15-A1AA-14E97766E12BQ27012437-8A917225-E68C-474C-98F8-C2F4F8A47C00Q31114426-2CBD22BF-6512-4C12-A76A-3D2EDF262E6EQ33597053-38642DCF-22BC-42E7-BAC8-04569B372C21Q33614592-D640120C-E145-49A9-88BE-73E36B351FD9Q33645453-7234ACB6-592F-46EF-B1AE-98B1EA5D369BQ33785821-B248AB64-EC07-40B7-AF85-9AB77A77AB03Q33787213-83D210D0-960D-4C42-8A45-BFEAEFAAFD23Q33790853-1751DA97-4D18-41F5-94C3-AF074162D85CQ33914523-884D4925-7D60-41E3-B732-0A4BDED65627Q34203055-1AEC5160-27F5-496F-B400-26069FE72AA9Q34205990-CE602D26-65FA-420C-869E-DF273767954CQ34278027-2EAF76B6-6205-4AB2-B5ED-199BC23110A6Q34418342-E9D17849-8DBE-401E-B04D-9A3D7DF78C3FQ34657504-78C5AEB7-BC09-4427-8EE8-723952C13FDEQ35471803-2C0CDB02-AAD5-4686-8E57-4B4FB4173CB0Q36141486-7DE17ADD-06C1-4AAB-9911-56736103156CQ36298126-360552B2-102C-4B21-BD79-7B9E6A8F9B8AQ36332493-CE41A9B8-8268-43EA-BAF3-E6D189388232Q36625033-83F95684-9237-47C0-B1B4-F0503BC12D40Q36692356-C530A894-F124-4504-A63D-FB43F58868E6Q36772194-CEB9F008-8761-47D8-B5AB-48EC6A92B4F2Q36803338-E259F52A-0B17-43A1-B72E-697B9646B7A4Q36855988-DFFC143B-0F51-48DB-BAA2-F32953B6CB56Q36961519-7B35352A-F2A5-4C7F-BEAD-72D3BE67A806Q37120223-02FA65E0-4463-4516-8E90-AC9E32E39723Q38070731-D150926C-F888-47A9-B91C-D93F0BFC5F96Q38218704-220C9FF5-3354-4E05-ADA8-890DB0881CCFQ38579951-9A6BE2EC-A640-42EF-B02D-CB66A4562162Q39371715-B487D09F-40B5-458C-8E7B-E67B1AFEA108Q39919696-B86AAF32-8DA6-45B2-B1AA-1FA05998813BQ40414427-CCAF7F6D-7AA6-4008-AA1F-A37F655F4302Q40772391-A19845F6-B6DE-4B4F-B9AC-FADD970D63DEQ41122998-FEEF3982-F867-4D65-BCF6-C15A90CBA23CQ42612004-0F0111FE-C51B-49F6-BD5E-287B4902512CQ42671135-1061984A-9909-4278-88BF-995AB785485EQ43277046-4390D7FF-26A6-41CB-9F8A-9D70CED98EBFQ43885692-67582053-A14B-4E72-BFA0-7B8AC473C484Q44015350-409653E2-54E4-4042-A0E6-076169EF6EEDQ45105201-CA660FD4-EAAF-45AA-9FCF-2F21D541FADE
P2860
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@ast
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@en
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@nl
type
label
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@ast
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@en
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@nl
prefLabel
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@ast
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@en
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@nl
P1433
P1476
The impact of migraine: Epidemiology, risk factors, and co-morbidities.
@en
P2093
Rasmussen BK
P356
10.1212/WNL.56.SUPPL_1.S4
P407
P433
P577
2001-01-01T00:00:00Z